Henry Schein (HSIC) Q1 Earnings Beat Estimates
Henry Schein (HSIC) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.10 per share a year ago.
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HSIC Gears Up for Q1 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive Q1 2025 sales in each of its business segment and a positive pace of recovery from the cyber incident.
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Henry Schein Looks Bullish (Technical Analysis)
HSIC shows bullish price action, momentum, volume, and relative strength, making it an attractive investment with a 2.6 reward-to-risk ratio. The stock is in an uptrend, trading above its 30-week EMA, and has bullish short-term and long-term momentum as indicated by the PPO. Institutional buying supports bullish volume trends, and HSIC has been outperforming the S&P 500 since December 2024.
Henry Schein: An Industry Leader That Offers Some Upside From Here
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.
Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Graham Stanley - Vice President of Investor Relations & Strategic Financial Project Officer Stanley Bergman - Chairman & Chief Executive Officer Ronald South - Senior Vice President & Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Jeffrey Johnson - Baird Allen Lutz - Bank of America John Stansel - JPMorgan Jonathan Block - Stifel Kevin Caliendo - UBS Brandon Vazquez - William Blair Elizabeth Anderson - Evercore ISI Operator Good morning ladies and gentlemen and welcome to Henry Schein's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth
On Tuesday, Henry Schein Inc. HSIC reported a fourth-quarter adjusted EPS of $1.19, up 80.3% year-over-year, missing the consensus of $1.21.
Henry Schein (HSIC) Meets Q4 Earnings Estimates
Henry Schein (HSIC) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago.
Henry Schein forecasts 2025 profit below estimates on weak demand for dental products
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Unveiling Henry Schein (HSIC) Q4 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
